Dotters Deborah MD - OR Lane, Springfield 97477

Dotters Deborah MD entered the industry of Gynecologists and OB GYNs in 1997 and has grown to employ 1 to 4 people, generating an annual revenue of $500.000 to $999.999. The NAICS classifies this business under the code 6211110, which describes it as a Gynecologists and OB GYNs. For further clarification, the SIC classifies this business under the code 8011 and described it as a Gynecologists and OB GYNs. The business provides service to the B2C market.

To acquire more information, please contact Deborah Dotters by calling (541) 465-3300 during business hours. You can also write to the business’ Single Location at 3377 Riverbend Drive # 500, Springfield, Oregon OR 97477. You can also visit the company’s website at organcancer.com. View this business’ social media profiles on Twitter or on Facebbok .

Company: Dotters Deborah MD
Representative: Deborah Dotters
Place of Business: 3377 Riverbend Drive # 500, Springfield, OR 97477
Contact Number: (541) 465-3300
Website: organcancer.com
Type of Service: Gynecologists and OB GYNs
SIC Number: 8011
NAICS Number: 6211110
Locality: Single Location
Market Type: B2C (Business to Consumer)
Began: 1997
Income/Year: $500.000 to $999.999
Laborers: 1 to 4
Share This Company:

Dotters Deborah MD is a company operating from Lane, Oregon providing professional Gynecologists and OB GYNs and relevant B2C variables. It was founded in 1997 and registered with the SIC code 8011 as Gynecologists and OB GYNs, and with the NAICS code 6211110 as Gynecologists and OB GYNs.

With a current employee count of 1 to 4, Dotters Deborah MD has gone to report making $500.000 to $999.999 per annum on its journey towards growth. This company invites you to contact its representative Deborah Dotters at (541) 465-3300 for related queries, or to locate its Single Location using the coordinates 44.08334,-123.02785.

The Single Location can also be found at the street address 3377 Riverbend Drive # 500 in Springfield, Oregon 97477 and can be engaged online through the company website at organcancer.com, the company Twitter , and Facebook page .